LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Symbiotec Pharmalab
03 1DKSH
04 1TAPI Technology & API Services
05 1Anhui Sinotech Industrial
06 1CHEMO
07 1Curia
08 1Formosa Laboratories
09 2Gedeon Richter
10 1Green Stone Swiss Co ., Ltd
11 1Guangzhou Tosun Pharmaceutical
12 1Hangzhou Think Chemical Co.Ltd
13 1Industriale Chimica
14 1Maiden Group
15 1NEWCHEM SPA
16 1Naari
17 1Nanjing Bold Chemical
18 1Swati Spentose
19 1Teva Pharmaceutical Industries
01 5China
02 2Hungary
03 4India
04 2Israel
05 2Italy
06 1Spain
07 1Switzerland
08 1Taiwan
09 2U.S.A
01 6Active
02 1Inactive
03 13Blank
01 20Blank
01 1301MF10081
02 19Blank
01 20Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-24
Pay. Date : 2014-02-24
DMF Number : 27945
Submission : 2014-04-13
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-07-17
Pay. Date : 2024-05-28
DMF Number : 32954
Submission : 2018-07-27
Status : Active
Type : II
NDC Package Code : 63190-0870
Start Marketing Date : 2024-07-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26861
Submission : 2013-02-04
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-09-23
Pay. Date : 2018-05-18
DMF Number : 32234
Submission : 2017-11-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 21527
Submission : 2008-04-11
Status : Active
Type : II
Registration Number : 301MF10081
Registrant's Address : Parque Tecnologico-Parcela 105 Boecillo (Valladolid) Spain
Initial Date of Registration : 2019-10-25
Latest Date of Registration :
Registrant Name : Hyundai Pharmaceutical Co., Ltd.
Registration Date : 2011-07-14
Registration Number : Number 2395-1-ND
Manufacturer Name : CURIA SPAIN SAU
Manufacturer Address : Parque Tecnologico de Boecillo, Parcela 105, 47151-Boecillo (Valladolid)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25701
Submission : 2012-01-09
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12920
Submission : 1998-04-07
Status : Inactive
Type : II
A Ulipristal Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ulipristal Acetate, including repackagers and relabelers. The FDA regulates Ulipristal Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ulipristal Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ulipristal Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ulipristal Acetate supplier is an individual or a company that provides Ulipristal Acetate active pharmaceutical ingredient (API) or Ulipristal Acetate finished formulations upon request. The Ulipristal Acetate suppliers may include Ulipristal Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Ulipristal Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 19 companies offering Ulipristal Acetate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?